NASDAQ:TSHA

Taysha Gene Therapies Stock News

etoro logo Buy TSHA
*Your capital is at risk
$5.86
-0.0150 (-0.255%)
At Close: Jul 31, 2026
DALLAS, May 04, 2023 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the tr
Taysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Hayleigh Collins - Director and Head of Corporate Communications Sean Nolan -
Taysha has a good chance of scoring with the GAN indication. Astellas may license this program if that happens.
Biotech penny stocks to watch this week. Are they a buy now?
Shares have fallen by 85% since Sept 2020 IPO as cash resources dwindled to $34M as of last month. Company was forced to cut 35% of workforce, stop construction of its cGMP manufacturing facility and
Taysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q3 2022 Results Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session - Preside
Analysts say these are penny stocks to buy. Do you agree?
DALLAS, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene the

Buying Penny Stocks? 3 Technical Indicators to Use

06:00am, Wednesday, 26'th Oct 2022
Use these technical indicators for trading penny stocks right now The post Buying Penny Stocks? 3 Technical Indicators to Use  appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
Taysha Gene Therapies (NASDAQ: TSHA ) jumped 50% overnight after Japan's Astellas Pharma (OTCMKTS: ALPMY ) bought 15% of the company and exclusive marketing rights to its genetic therapies. Taysha is
Conference call and webcast on Tuesday, October 25 at 8:00 AM ET Conference call and webcast on Tuesday, October 25 at 8:00 AM ET
Taysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q2 2022 Results Conference Call August 11, 2022 8:00 AM ET Company Participants Dr. Kimberly Lee - Chief Corporate Affairs Officer RA Session - President, Fo
DALLAS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene the
BTIG Biotechnology Conference on August 8, 2022 at 12:00 pm ET
Taysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session II - President, Found
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE